Alterity Therapeutics (ATHE) Other Non Operating Income (2014 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Other Non Operating Income of $12282.6 for Q4 2025, up 107.28% year-over-year from $5925.6 in Q4 2024, and up 107.28% quarter-over-quarter from -$168754.2 in Q4 2024.
Alterity Therapeutics (ATHE) Other Non Operating Income (2014 - 2025) Analysis & Trends
Alterity Therapeutics' Other Non Operating Income history runs 11 years deep, the most recent figure standing at $12282.6 for Q4 2025.
- In Q4 2025, Other Non Operating Income rose 107.28% year-over-year to $12282.6; the TTM figure through Dec 2025 stood at -$449955.0 (up 66.67% YoY), while the FY2024 annual figure was -$261.2 billion, up 71.54% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $12282.6, up from -$168754.2 in the prior quarter.
- The five-year high for Other Non Operating Income was $12282.6 in Q4 2025, with the low at -$887856.6 in Q4 2021.
- The 5-year median for Other Non Operating Income is -$168754.2 (2024), against an average of -$267562.3.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income slumped 7673.09% in 2024, then jumped 107.28% in 2025.
- Alterity Therapeutics' Other Non Operating Income stood at -$887856.6 in 2021, then soared by 66.69% to -$295711.7 in 2022, then jumped by 100.75% to $2228.3 in 2023, then plunged by 7673.09% to -$168754.2 in 2024, then soared by 107.28% to $12282.6 in 2025.
- Business Quant data shows ATHE's Other Non Operating Income at $12282.6 in Q4 2025, -$168754.2 in Q4 2024, and $2228.3 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12,282.56 |
| Dec 31, 2024 | -168,754.15 |
| Dec 31, 2023 | 2,228.34 |
| Dec 31, 2022 | -295,711.72 |
| Dec 31, 2021 | -887,856.63 |
| Dec 31, 2019 | -87,328.62 |
| Dec 31, 2018 | -142,967.80 |
| Dec 31, 2017 | 469,835.65 |
| Dec 31, 2016 | -372,092.82 |
| Dec 31, 2015 | 1.90 Mn |
| Dec 31, 2014 | 5.57 Mn |